Neuroscience
From Fierce Biotech:
UCSF enters drug discovery agreement with Genentech
Posted February 19, 2010
Read the full article
- And The Darpa Deep Brain Stimulation Awards Go To...
...UCSF and MGH! Work on DARPA’s Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) program is set to begin with teams led by UC San Francisco (UCSF), and Massachusetts General Hospital (MGH). The SUBNETS program seeks to reduce the severity...
- Clinical Trials: Evp-6124 Phase 2b Clinical Trial In Schizophrenia
From Drug Discovery & Development: Positive Study Results for Schizophrenia Drug Drug Discovery & Development December 05, 2011 "EnVivo Pharmaceuticals announced the analysis of a completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable...
- Elan And University Of Cambridge To Create Neurodegenerative Research Institute
Elan to create research centre with Cambridge University DUBLIN Sun Nov 27, 2011 4:14am EST "(Reuters) - Elan Corp Plc has signed an agreement with Britain's Cambridge University to create a research center focused on therapies for Alzheimer's...
- Uc San Francisco-pfizer Drug Development Partnership
From EurekaAlert: UCSF-Pfizer partnership yields projects aimed at clinical trials 26 October 2011 Read the full article...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...
Neuroscience
Neurodegenerative Disease Drug Discovery: UCSF and Genentech
From Fierce Biotech:
UCSF enters drug discovery agreement with Genentech
Posted February 19, 2010
"The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
"Through the agreement, Genentech will provide funding and its research acumen in neuroscience and will collaborate with UCSF to identify small molecules."
Read the full article
- And The Darpa Deep Brain Stimulation Awards Go To...
...UCSF and MGH! Work on DARPA’s Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) program is set to begin with teams led by UC San Francisco (UCSF), and Massachusetts General Hospital (MGH). The SUBNETS program seeks to reduce the severity...
- Clinical Trials: Evp-6124 Phase 2b Clinical Trial In Schizophrenia
From Drug Discovery & Development: Positive Study Results for Schizophrenia Drug Drug Discovery & Development December 05, 2011 "EnVivo Pharmaceuticals announced the analysis of a completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable...
- Elan And University Of Cambridge To Create Neurodegenerative Research Institute
Elan to create research centre with Cambridge University DUBLIN Sun Nov 27, 2011 4:14am EST "(Reuters) - Elan Corp Plc has signed an agreement with Britain's Cambridge University to create a research center focused on therapies for Alzheimer's...
- Uc San Francisco-pfizer Drug Development Partnership
From EurekaAlert: UCSF-Pfizer partnership yields projects aimed at clinical trials 26 October 2011 Read the full article...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...